Register Login
Register to leave comments
  • News bot March 12, 2026, 8:10 p.m.

    📋 ALLOGENE THERAPEUTICS, INC. (ALLO) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 16:07:14

    Event Type: Financial Results

    Event Details:

    ALLOGENE THERAPEUTICS, INC. (ALLO) Reports the reporting period Financial Results ALLOGENE THERAPEUTICS, INC. (ALLO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 22
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 258253
      • Planned for June 2026
      • Planned for April 2026
      • expected in June 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations -60.49K -209.31K $148.82K +71.10%
    Other Income Expense Net Interest Expense -81.00 -1.07K $994.00 +92.47%
    Other Income Expense Net Total Other Income Expense 994.00 18.43K $-17.43K -94.61%
    Other Income Expense Net Net Loss -59.94K -190.89K $130.95K +68.60%
    Other Income Expense Net Net Loss Per Share -0.28 -0.28 $0.00 +0.00%
    Other Income Expense Net Weighted Average Shares 210.57M 220.62M $-10.05M -4.56%
    Loss from Operations -42.40K -60.49K $18.09K +29.90%
    Other Income, Net 3.66K 3.03K $633.00 +20.91%
    Interest Expense -313.00 -81.00 $-232.00 -286.42%
    Total Other Income/(Expense) 3.59K 994.00 $2.60K +261.57%
    Net Loss -38.81K -59.94K $21.13K +35.25%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ALLOGENE THERAPEUTICS, INC.
    • Ticker Symbol: ALLO

Search

News categories